The digital polymerase chain reaction (PCR) market is witnessing significant advancements, particularly in the development of more precise and sensitive PCR instruments and assays. These innovations cater to applications in genomics, diagnostics, and molecular research. Among the segments, the dominating category is real-time digital PCR, which offers real-time quantification and improved accuracy in detecting target DNA sequences. Its applications in disease diagnosis, gene expression analysis, and environmental monitoring reinforce its position as a leading segment in the digital PCR market.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-digital-pcr-market
Data Bridge Market Research analyses that the Global Digital Polymerase Chain Reaction (PCR) Market is expected to reach USD 13,586.21 million by 2030 from USD 6,149.09 million in 2022, growing at a CAGR of 11.1% in the forecast period of 2023 to 2030. The proliferation of genomics research initiatives demands PCR platforms that can handle large-scale and high-throughput DNA analysis efficiently. Robust and advanced PCR technologies meet this need, facilitating comprehensive genomic studies and accelerating scientific discoveries in genomics research.
Key Findings of the Study
Environmental monitoring is expected to drive the market's growth rate
PCR-based assays are indispensable in environmental monitoring and pathogen detection. They enable the precise identification and quantification of microorganisms, pollutants, and genetic markers in various environmental samples. These assays are vital for tracking water quality, assessing soil contamination, and identifying disease-causing pathogens in air, water, and soil. The rapid and accurate results provided by PCR-based assays help safeguard public health, ensure food safety, and protect ecosystems by facilitating timely interventions and mitigation measures.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Digital PCR Instruments, Consumables and Reagents, Software and Services), Technology (Droplet Digital PCR and Beaming Digital PCR), Application (Clinical, Life Science and Research, and Others), End Users (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Reference Laboratories, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), Eppendorf SE (Germany), Sysmex Corporation (Japan), Stilla (France), RainSure Scientific (U.S.), Accumax (India), Standard BioTools (U.S.), JN Medsys (Singapore), VSI Electronics Pvt. Ltd (India), Precigenome LLC (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global digital polymerase chain reaction (PCR) market is segmented into five notable segments based on product type, technology, application, end user, and distribution channel.
- On the basis of product type, the market is segmented into digital PCR instruments, consumables and reagents, and software and services.
- On the basis of technology, the market is segmented into droplet digital PCR and beaming digital PCR.
- On the basis of application, the market is segmented into clinical, life science and research, and others.
- On the basis of end user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and clinics, diagnostic laboratories, academic and research organizations, reference laboratories, and others.
- On the basis of distribution channel, the market is segmented into direct tenders, retail sales, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major global digital polymerase chain reaction (PCR) market players in global digital polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), Eppendorf SE (Germany), Sysmex Corporation (Japan), Stilla (France), RainSure Scientific (U.S.), Accumax (India), Standard BioTools (U.S.), JN Medsys (Singapore).
Market Developments
- In July 2023, QIAGEN has broadened its digital PCR kit and service offerings for the biopharmaceutical sector through a collaboration with Niba Labs. This partnership aims to provide tailored digital PCR (dPCR) assay design services to biopharmaceutical clients. It leverages Niba Labs' analytical laboratory proficiency in digital PCR assay development and sample analysis. This collaborative effort empowers quality customers to access the combined expertise of both organizations, facilitating the creation of custom nucleic acid quantification assays, whether simplex and multiplex.
- In October 2022, Standard BioTools Inc. unveiled its latest innovation, the X9 Real-Time PCR system. This advanced platform is designed to offer precise and efficient real-time polymerase chain reaction (PCR) capabilities, catering to the needs of researchers and laboratories. With features such as rapid cycling and enhanced sensitivity, the X9 system enables accurate DNA amplification and analysis, making it a valuable tool for molecular biology, diagnostics, and genomics applications.
- Thermo Fisher Scientific Inc. introduced the Applied Biosystems QuantStudio Absolute Q Digital PCR (dPCR) System. This innovative system is designed to provide highly accurate and absolute quantification of nucleic acids in a wide range of applications. Leveraging digital PCR technology, it offers researchers a precise and reliable tool for quantifying target DNA or RNA sequences, making it invaluable for various fields such as genomics, diagnostics, and molecular research.
Regional Analysis
Geographically, the countries covered in the major global digital polymerase chain reaction (PCR) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America dominates global digital polymerase chain reaction (PCR) market during the forecast period 2023 - 2030
North America dominates the digital polymerase chain reaction (PCR) market, driven by substantial investments in this technology. Within the region, the United States is poised for dominance, primarily owing to the robust presence of major industry players. The concentration of key players and significant investment initiatives reinforce the U.S.'s leading role in advancing digital PCR technology and its applications within North America.
Europe is expected to dominate the global digital polymerase chain reaction (PCR) market during the forecast period 2023 - 2030
In Europe, Germany is expected to dominate the digital polymerase chain reaction (PCR) market. This dominance is attributed to rising demand stemming from emerging markets and the country's continuous expansion efforts. Germany's strategic position as an economic powerhouse within Europe, coupled with its strong focus on technological advancements, positions it as a hub for digital PCR adoption and development, driving its dominance in the region.
For more detailed information about the global digital polymerase chain reaction (PCR) market report, click here – https://www.databridgemarketresearch.com/ar/reports/global-digital-pcr-market
